SCHEDULE 13G/A 0001747888 XXXXXXXX LIVE 1 Common stock, par value $0.01 09/30/2025 0001831097 agilon health, inc. 00857U107 6210 E HWY 290 Suite 450 Austin TX 78723 Rule 13d-1(c) North Peak Capital Management, LLC DE 0.00 31971936.00 7440021.00 31971936.00 39411957.00 N 9.5 IA OO The figures in Items 6, 8, and 9 include (1) 2,193,338 shares of Common stock, par value $0.01 ("Common Stock") of agilon health, inc. (the "Issuer") held directly by North Peak Capital Partners, LP, (2) 18,382,413 shares of Common Stock held directly by North Peak Capital Partners II, LP, (3) 9,840,951 shares of Common Stock held directly by North Peak Capital Alpha Fund, LP and (4) 1,555,234 shares of Common Stock held directly by North Peak Capital Ultra Fund, LP. The figure in Item 11 is based upon 414,581,604 Common Stock outstanding as of October 30, 2025, as disclosed in the Issuer's quarterly report on Form 10-Q for the quarterly period ended September 30, 2025 filed with the U.S. Securities and Exchange Commission (the "Commission") on November 4, 2025. North Peak Capital GP, LLC DE 0.00 31971936.00 0.00 31971936.00 31971936.00 N 7.7 OO The figures in Items 6, 8, and 9 include (1) 2,193,338 shares of Common Stock held directly by North Peak Capital Partners, LP, (2) 18,382,413 shares of Common Stock held directly by North Peak Capital Partners II, LP, (3) 9,840,951 shares of Common Stock held directly by North Peak Capital Alpha Fund, LP and (4) 1,555,234 shares of Common Stock held directly by North Peak Capital Ultra Fund, LP. The figure in Item 11 is based upon 414,581,604 Common Stock of the Issuer outstanding as of October 30, 2025, as disclosed in the Issuer's quarterly report on Form 10-Q for the quarterly period ended September 30, 2025, filed with the Commission on November 4, 2025. North Peak Capital Partners, LP DE 0.00 2193338.00 0.00 2193338.00 2193338.00 N 0.5 PN The figure in Item 11 is based upon 414,581,604 Common Stock of the Issuer outstanding as of October 30, 2025, as disclosed in the Issuer's quarterly report on Form 10-Q for the quarterly period ended September 30, 2025, filed with the Commission on November 4, 2025. North Peak Capital Partners II, LP DE 0.00 18382413.00 0.00 18382413.00 18382413.00 N 4.4 PN The figure in Item 11 is based upon 414,581,604 Common Stock of the Issuer outstanding as of October 30, 2025, as disclosed in the Issuer's quarterly report on Form 10-Q for the quarterly period ended September 30, 2025, filed with the Commission on November 4, 2025. North Peak Capital Alpha Fund, LP DE 0.00 9840951.00 0.00 9840951.00 9840951.00 N 2.4 PN The figure in Item 11 is based upon 414,581,604 Common Stock of the Issuer outstanding as of October 30, 2025, as disclosed in the Issuer's quarterly report on Form 10-Q for the quarterly period ended September 30, 2025, filed with the Commission on November 4, 2025. North Peak Capital Ultra Fund, LP DE 0.00 1555234.00 0.00 1555234.00 1555234.00 N 0.4 PN The figure in Item 11 is based upon 414,581,604 Common Stock of the Issuer outstanding as of October 30, 2025, as disclosed in the Issuer's quarterly report on Form 10-Q for the quarterly period ended September 30, 2025, filed with the Commission on November 4, 2025. Michael Kevin Kahan X1 0.00 31971936.00 0.00 31971936.00 31971936.00 N 7.7 HC IN The figures in Items 6, 8, and 9 include (1) 2,193,338 shares of Common Stock held directly by North Peak Capital Partners, LP, (2) 18,382,413 shares of Common Stock held directly by North Peak Capital Partners II, LP, (3) 9,840,951 shares of Common Stock held directly by North Peak Capital Alpha Fund, LP and (4) 1,555,234 shares of Common Stock held directly by North Peak Capital Ultra Fund, LP. The figure in Item 11 is based upon 414,581,604 Common Stock of the Issuer outstanding as of October 30, 2025, as disclosed in the Issuer's quarterly report on Form 10-Q for the quarterly period ended September 30, 2025, filed with the Commission on November 4, 2025. Jeremy Steven Kahan X1 0.00 31971936.00 0.00 31971936.00 31971936.00 N 7.7 HC CO The figures in Items 6, 8, and 9 include (1) 2,193,338 shares of Common Stock held directly by North Peak Capital Partners, LP, (2) 18,382,413 shares of Common Stock held directly by North Peak Capital Partners II, LP, (3) 9,840,951 shares of Common Stock held directly by North Peak Capital Alpha Fund, LP and (4) 1,555,234 shares of Common Stock held directly by North Peak Capital Ultra Fund, LP. The figure in Item 11 is based upon 414,581,604 Common Stock of the Issuer outstanding as of October 30, 2025, as disclosed in the Issuer's quarterly report on Form 10-Q for the quarterly period ended September 30, 2025, filed with the Commission on November 4, 2025. agilon health, inc. 6210 E HWY 290, Suite 450, Austin, TX, 78723 This statement is jointly filed by and on behalf of each of North Peak Capital Management, LLC, a Delaware limited liability company ("North Peak Management"), North Peak Capital GP, LLC, a Delaware limited liability company ("North Peak GP"), North Peak Capital Partners, LP, a Delaware limited partnership ("Fund I"), North Peak Capital Partners II, LP, a Delaware limited partnership ("Fund II"), North Peak Capital Alpha Fund, LP, a Delaware limited partnership ("Alpha Fund"), North Peak Capital Ultra Fund, LP, a Delaware limited partnership ("Ultra Fund"), Jeremy S. Kahan and Michael K. Kahan (each, a "Reporting Person" and collectively, the "Reporting Persons"). North Peak Management is the investment manager of, and may be deemed to indirectly beneficially own securities owned by, each of Fund I, Fund II, Alpha Fund and Ultra Fund. North Peak Management is also an investment adviser to a separately managed account of an advisory client and may be deemed to beneficially own securities directly in such separately managed account, but North Peak Management does not have any voting authority with respect to any securities in such separately managed account. North Peak GP is the general partner of, and may be deemed to indirectly beneficially own securities owned by, each of Fund I, Fund II, Alpha Fund and Ultra Fund. Messrs. Kahan are the co-managers of, and each may be deemed to indirectly beneficially own securities beneficially owned by, each of North Peak Management and North Peak GP. Each Reporting Person disclaims beneficial ownership of the shares of Common Stock held directly by the other Reporting Persons. Each Reporting Person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such Reporting Person is, for the purposes of Section 13(d) or 13(g) of the Act or any other purpose, the beneficial owner of any securities covered by this statement. Each Reporting Person may be deemed to be a member of a group with respect to the Issuer or securities of the Issuer for the purposes of Section 13(d) or 13(g) of the Act. Each of the Reporting Persons declares that neither the filing of this statement nor anything herein shall be construed as an admission that such Reporting Person is, for the purposes of Section 13(d) or 13(g) of the Act or any other purpose, (i) acting (or has agreed or is agreeing to act together with any other person) as a partnership, limited partnership, syndicate, or other group for the purpose of acquiring, holding, or disposing of securities of the Issuer or otherwise with respect to the Issuer or any securities of the Issuer or (ii) a member of any group with respect to the Issuer or any securities of the Issuer. The address of the principal business office of each of the Reporting Persons is c/o North Peak Capital Management, LLC, 405 Lexington Avenue, Suite 5001, New York, NY 10174. See Item 4 on the cover page(s) hereto. Y See Item 9 on the cover page(s) hereto. See Item 11 on the cover page(s) hereto. See Item 5 on the cover page(s) hereto. See Item 6 on the cover page(s) hereto. See Item 7 on the cover page(s) hereto. See Item 8 on the cover page(s) hereto. Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. Exhibit 99.1. Joint Filing Agreement (incorporated herein by reference to Exhibit 99.1 to the Schedule 13G filed on August 29, 2025, by the Reporting Persons with the SEC). North Peak Capital Management, LLC /s/ Jeremy Kahan 11/13/2025 North Peak Capital GP, LLC /s/ Jeremy Kahan 11/13/2025 North Peak Capital Partners, LP North Peak Capital GP, LLC 11/13/2025 /s/ Jeremy Kahan 11/13/2025 North Peak Capital Partners II, LP North Peak Capital GP, LLC 11/13/2025 /s/ Jeremy Kahan 11/13/2025 North Peak Capital Alpha Fund, LP North Peak Capital GP, LLC 11/13/2025 /s/ Jeremy Kahan 11/13/2025 North Peak Capital Ultra Fund, LP North Peak Capital GP, LLC 11/13/2025 /s/ Jeremy Kahan 11/13/2025 Michael Kevin Kahan /s/ Michael Kahan 11/13/2025 Jeremy Steven Kahan /s/ Jeremy Kahan 11/13/2025